EarliTec Diagnostics today announced its rebrand as EarliPoint Health, marking a bold new chapter in the company’s mission to transform autism care.
EarliTec Diagnostics, a leader in eye-tracking technology for early autism diagnosis and ongoing assessment, announced the appointment of Jamie Pagliaro as its
Key Takeaways Quality can slip if practices expand too quickly without systems and safeguards in place. Protecting clinical integrity must be a
Key Takeaways Financial planning is the backbone of sustainable ABA growth. Without it, practices risk overspending, cash flow issues, and unstable expansion.
Key Takeaways A strategic growth plan provides clarity and direction. Without one, practices risk expanding reactively and unsustainably. Vision and priorities set
Key Takeaways Understanding your audience’s needs and habits ensures your marketing reaches the right families and referral sources. A strong local search
For parents, hearing their child respond to their name for the first time is a special milestone. It signifies recognition, connection, and
As a parent, watching your baby’s development is an exciting journey filled with milestones like their first smile, laugh, and steps. One
Understanding Early Social Development Eye contact is one of the earliest ways babies connect with their caregivers. From infancy, most babies naturally
Why Early Detection Matters Every child develops at their own pace, but when certain social, communication, or behavioral milestones are missing, it
Every year, thousands of children miss critical windows for early autism intervention—simply because diagnostic tools rely too much on subjective observation.20,31-37 Once that
Key Takeaways For ABA clinics, social media isn’t just a place to post occasional updates—it’s a powerful tool for connecting with families,
Using clinically validated measures, we are creating novel technologies that enable parents and providers to know where an individual child is on the spectrum and to tailor treatment for the greatest personal gains.
Jamie Pagliaro brings over two decades of leadership in autism and behavioral health to his role as President and CEO of EarliPoint. Most recently, he served as Chief Operating Officer at Rethink, a leading SaaS provider supporting individuals with autism and developmental disabilities. Under his leadership, Rethink’s behavioral health division became the company’s largest business unit, serving thousands of clinicians and driving scalable, tech-enabled care delivery.
Earlier in his career, Jamie was Executive Director of the New York Center for Autism Charter School, the first public charter school in New York State dedicated to children with autism. At EarliPoint, he leads the company’s mission to bring breakthrough science to the front lines of care—empowering providers, families, and health systems with earlier answers and better outcomes.
Dr. Ami Klin is a globally recognized leader in autism research and early detection. As Director of the Marcus Autism Center and Division Chief of Autism and Developmental Disabilities at Emory University School of Medicine, he has dedicated his career to understanding how young children engage with the social world—and how subtle disruptions in attention can signal developmental differences. His pioneering work in eye-tracking science led to the development of EarliPoint™ Evaluation, the first FDA-authorized tool to objectively assess autism in children as young as 16 months.
At EarliPoint, Dr. Klin drives clinical strategy and innovation, ensuring that families and clinicians worldwide have access to timely, science-based insights that enable earlier, more personalized intervention. His career reflects a deep commitment to transforming how society supports children with autism—starting with the earliest signs.